(Q38181064)

English

Use of Magnetic Resonance Imaging as Well as Clinical Disease Activity in the Clinical Classification of Multiple Sclerosis and Assessment of Its Course: A Report from an International CMSC Consensus Conference, March 5-7, 2010

scientific article published on January 2012

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

30 August 2017

Use of Magnetic Resonance Imaging as Well as Clinical Disease Activity in the Clinical Classification of Multiple Sclerosis and Assessment of Its Course: A Report from an International CMSC Consensus Conference, March 5-7, 2010 (English)

1 reference

Europe PubMed Central

PMC publication ID

30 August 2017

multiple sclerosis

0 references

Gavin Giovannoni

6

object named as

Gavin Giovannoni

1 reference

Europe PubMed Central

PMC publication ID

30 August 2017

author name string

Stuart D Cook

1

1 reference

Europe PubMed Central

PMC publication ID

30 August 2017

Suhayl Dhib-Jalbut

2

1 reference

Europe PubMed Central

PMC publication ID

30 August 2017

Peter Dowling

3

1 reference

Europe PubMed Central

PMC publication ID

30 August 2017

Luca Durelli

4

1 reference

Europe PubMed Central

PMC publication ID

30 August 2017

Corey Ford

5

1 reference

Europe PubMed Central

PMC publication ID

30 August 2017

June Halper

7

1 reference

Europe PubMed Central

PMC publication ID

30 August 2017

Colleen Harris

8

1 reference

Europe PubMed Central

PMC publication ID

30 August 2017

Joseph Herbert

9

1 reference

Europe PubMed Central

PMC publication ID

30 August 2017

David Li

10

1 reference

Europe PubMed Central

PMC publication ID

30 August 2017

John A Lincoln

11

1 reference

Europe PubMed Central

PMC publication ID

30 August 2017

Robert Lisak

12

1 reference

Europe PubMed Central

PMC publication ID

30 August 2017

Fred D Lublin

13

1 reference

Europe PubMed Central

PMC publication ID

30 August 2017

Claudia F Lucchinetti

14

1 reference

Europe PubMed Central

PMC publication ID

30 August 2017

Wayne Moore

15

1 reference

Europe PubMed Central

PMC publication ID

30 August 2017

Robert T Naismith

16

1 reference

Europe PubMed Central

PMC publication ID

30 August 2017

Carlos Oehninger

17

1 reference

Europe PubMed Central

PMC publication ID

30 August 2017

Jack Simon

18

1 reference

Europe PubMed Central

PMC publication ID

30 August 2017

Maria Pia Sormani

19

1 reference

Europe PubMed Central

PMC publication ID

30 August 2017

publication date

1 January 2012

1 reference

Europe PubMed Central

PMC publication ID

30 August 2017

International journal of MS care

1 reference

Europe PubMed Central

PMC publication ID

30 August 2017

14

1 reference

Europe PubMed Central

PMC publication ID

30 August 2017

3

1 reference

Europe PubMed Central

PMC publication ID

30 August 2017

105-114

1 reference

Europe PubMed Central

PMC publication ID

30 August 2017

Survival in MS: a randomized cohort study 21 years after the start of the pivotal IFNβ-1b trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

6 September 2017

Multiple sclerosis: effects of cognitive rehabilitation on structural and functional MR imaging measures--an explorative study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

6 September 2017

Magnetic Resonance Techniques in Multiple Sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

6 September 2017

Inflammatory cortical demyelination in early multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

6 September 2017

Biomarkers of disease activity in multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

6 September 2017

MRI predictors of cognitive outcome in early multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

6 September 2017

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

6 September 2017

Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

6 September 2017

Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

6 September 2017

T2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

6 September 2017

Increased diffusivity in acute multiple sclerosis lesions predicts risk of black hole

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

6 September 2017

Progressive multiple sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

6 September 2017

New acute and chronic black holes in patients with multiple sclerosis randomised to interferon beta-1b or glatiramer acetate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

6 September 2017

In vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

6 September 2017

Quality of life in multiple sclerosis is associated with lesion burden and brain volume measures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

6 September 2017

MRI in multiple sclerosis: current status and future prospects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

6 September 2017

Magnetic resonance imaging as a surrogate outcome for multiple sclerosis relapses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

6 September 2017

Multi-parametric MR assessment of T(1) black holes in multiple sclerosis : evidence that myelin loss is not greater in hypointense versus isointense T(1) lesions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

6 September 2017

MRI relapses have significant pathologic and clinical implications in multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

6 September 2017

Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

6 September 2017

Magnetic resonance imaging as a surrogate outcome measure of disability in multiple sclerosis: have we been overly harsh in our assessment?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

6 September 2017

Standardized MR imaging protocol for multiple sclerosis: Consortium of MS Centers consensus guidelines.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

6 September 2017

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

6 September 2017

The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

6 September 2017

Is inflammation important in early PPMS? a longitudinal MRI study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

6 September 2017

Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

6 September 2017

Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

6 September 2017

Acute demyelination: diagnostic difficulties and the need for brain biopsy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

6 September 2017

PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

6 September 2017

Clinical and laboratory characteristics of secondary progressive MS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

6 September 2017

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

6 September 2017

T1 hypointensities and axonal loss

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

6 September 2017

A pathology-MRI study of the short-T2 component in formalin-fixed multiple sclerosis brain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

6 September 2017

Magnetization transfer imaging to monitor the evolution of multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

6 September 2017

Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

6 September 2017

Hypointense multiple sclerosis lesions on T1-weighted spin echo magnetic resonance images: their contribution in understanding multiple sclerosis evolution

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

6 September 2017

Axonal transection in the lesions of multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

6 September 2017

Guidelines for MRI monitoring of the treatment of multiple sclerosis: recommendations of the US Multiple Sclerosis Society's task force

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

6 September 2017

Defining the clinical course of multiple sclerosis: Results of an international survey

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

6 September 2017

Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with primary progressive multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

6 September 2017

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

6 September 2017

Multiple sclerosis: histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

6 September 2017

Pathophysiology of inflammation and tissue injury in multiple sclerosis: what are the targets for therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

14 September 2017

Early MRI in optic neuritis: the risk for disability

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

14 September 2017

Relationship of triple dose contrast enhanced lesions with clinical measures and brain atrophy in early relapsing-remitting multiple sclerosis: a two-year longitudinal study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

14 September 2017

Baseline MRI predicts future attacks and disability in clinically isolated syndromes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

14 September 2017

Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

28 September 2017

Surrogate endpoints in clinical trials: definition and operational criteria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

28 September 2017

Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

23 June 2018

Scales for rating impairment in multiple sclerosis: a critique.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

23 June 2018

The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

23 June 2018

Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

23 June 2018

Increased cerebral activation after behavioral treatment for memory deficits in MS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

31 August 2018

Combined MRI lesions and relapses as a surrogate for disability in multiple sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

31 August 2018

Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

31 August 2018

Focal multiple sclerosis lesions abound in 'normal appearing white matter'.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

31 August 2018

Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

31 August 2018

Magnetic resonance active lesions as individual-level surrogate for relapses in multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

31 August 2018

Cognitive impairment in relation to MRI metrics in patients with clinically isolated syndrome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

31 August 2018

Measuring myelin repair and axonal loss with diffusion tensor imaging.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

31 August 2018

Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

31 August 2018

MRI--the perfect surrogate marker for multiple sclerosis?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

31 August 2018

Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: a meta-analytic approach.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

31 August 2018

Clinical correlations of brain lesion distribution in multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

31 August 2018

Efficacy of treatment of MS with IFNbeta-1b or glatiramer acetate by monthly brain MRI in the BECOME study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

31 August 2018

Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

31 August 2018

Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

31 August 2018

Direct visualization of remyelination in multiple sclerosis using T2-weighted high-field MRI.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

31 August 2018

Disability as an outcome in MS clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

31 August 2018

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

31 August 2018

Predictors of long-term clinical response to interferon beta therapy in relapsing multiple sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

31 August 2018

Contrast-enhanced MRI lesions during treatment with interferonbeta-1b predict increase in T1 black hole volume in patients with relapsing-remitting multiple sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

31 August 2018

Defining interferon beta response status in multiple sclerosis patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

31 August 2018

Outcome measures for multiple sclerosis clinical trials: relative measurement precision of the Expanded Disability Status Scale and Multiple Sclerosis Functional Composite.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

31 August 2018

Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

31 August 2018

White matter and lesion T1 relaxation times increase in parallel and correlate with disability in multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

31 August 2018

Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

31 August 2018

Post-mortem high-resolution MRI of the spinal cord in multiple sclerosis: a correlative study with conventional MRI, histopathology and clinical phenotype.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

31 August 2018

Relapsing-remitting multiple sclerosis: longitudinal analysis of MR images--lack of correlation between changes in T2 lesion volume and clinical findings.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

31 August 2018

Disease activity in multiple sclerosis studied by weekly triple-dose magnetic resonance imaging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

31 August 2018

Magnetic resonance outcome of new enhancing lesions in patients with relapsing-remitting multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

31 August 2018

Gadoteridol in multiple sclerosis patients. A comparison of single and triple dose with immediate vs. delayed imaging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

31 August 2018

Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with MS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

31 August 2018

Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

31 August 2018

Triple-dose versus single-dose gadoteridol in multiple sclerosis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

31 August 2018

Frequency of cognitive impairment dramatically increases during the first 5 years of multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

1 October 2018

Post-marketing survey on clinical response to interferon beta in relapsing multiple sclerosis: the Roman experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

1 October 2018

Evolution of multiple sclerosis lesions on serial contrast-enhanced T1-weighted and magnetization-transfer MR images

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

5 November 2018

One year activity on subtraction MRI predicts subsequent 4 year activity and progression in multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

3 December 2018

Measures in the first year of therapy predict the response to interferon β in MS

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

3 December 2018

MRI as an outcome in multiple sclerosis clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

3 December 2018

MRI activity and neutralising antibody as predictors of response to interferon treatment in multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882992

3 December 2018

The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24453741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions

1 reference

https://pubmed.ncbi.nlm.nih.gov/24453741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

We should use magnetic resonance imaging to classify and monitor the course of multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24453741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serial magnetic resonance scanning in multiple sclerosis: a second prospective study in relapsing patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/24453741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical consequences of MRI activity in treated multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24453741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24453741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24453741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The radiologically isolated syndrome: is it very early multiple sclerosis?

1 reference

https://pubmed.ncbi.nlm.nih.gov/24453741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Picturing injury and recovery with diffusion tensor imaging: the eyes have it

1 reference

https://pubmed.ncbi.nlm.nih.gov/24453741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surrogate endpoints for EDSS worsening in multiple sclerosis: A meta-analytic approach

1 reference

https://pubmed.ncbi.nlm.nih.gov/24453741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A longitudinal study of T1 hypointense lesions in relapsing MS: MSCRG trial of interferon beta-1a. Multiple Sclerosis Collaborative Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/24453741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating event

1 reference

https://pubmed.ncbi.nlm.nih.gov/24453741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions

1 reference

https://pubmed.ncbi.nlm.nih.gov/24453741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Magnetic resonance imaging in multiple sclerosis]

1 reference

https://pubmed.ncbi.nlm.nih.gov/24453741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: a follow-up study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24453741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

One-year MRI scan predicts clinical response to interferon beta in multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24453741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cortical adaptation in patients with MS: a cross-sectional functional MRI study of disease phenotypes

1 reference

https://pubmed.ncbi.nlm.nih.gov/24453741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.7224/1537-2073-14.3.105

1 reference

Europe PubMed Central

PMC publication ID

30 August 2017

release_fa2oqjwcwrfe5hj3jvnpx3qpti

1 reference

https://api.fatcat.wiki/v0/release/fa2oqjwcwrfe5hj3jvnpx3qpti

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

30 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

30 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38181064&oldid=2176139814"